TAVR CPT Codes 2025: Comprehensive Billing, Reimbursement & Coverage Guide

Understanding the correct TAVR CPT code is paramount for accurate medical billing, ensuring timely reimbursement, and maintaining compliance in the ever-evolving landscape of cardiovascular procedures. Transcatheter Aortic Valve Replacement (TAVR) has revolutionized the treatment of severe aortic stenosis, offering a less invasive alternative to traditional open-heart surgery. However, the complexity of the procedure, coupled with specific payer requirements and ongoing clinical trials, makes its billing a nuanced challenge for healthcare providers. This comprehensive guide for 2025 (and looking ahead to 2026) aims to demystify TAVR CPT codes, reimbursement policies, and coverage criteria, equipping billing professionals with the knowledge to navigate this intricate domain successfully.

Quick Reference Guide

Navigating TAVR billing begins with a solid understanding of the core CPT codes and their associated rules. This quick reference table provides an at-a-glance overview of the primary codes and essential considerations.

CPT Code	Description	Key Billing Notes	Typical Facility/Professional
33361	Transcatheter aortic valve implantation (TAVI)/replacement (TAVR) with prosthetic valve; percutaneous femoral artery approach	Most common TAVR approach. Requires specific documentation for medical necessity and often clinical trial participation for Medicare.	Both
33362	Transcatheter aortic valve implantation (TAVI)/replacement (TAVR) with prosthetic valve; open femoral artery approach	Used when percutaneous access is not feasible, requiring a surgical cut-down.	Both
33363	Transcatheter aortic valve implantation (TAVI)/replacement (TAVR) with prosthetic valve; open subclavian artery approach	Alternative access site for patients unsuitable for femoral access.	Both
33364	Transcatheter aortic valve implantation (TAVI)/replacement (TAVR) with prosthetic valve; open direct aortic approach	Direct access via a mini-thoracotomy or sternotomy.	Both
33365	Transcatheter aortic valve implantation (TAVI)/replacement (TAVR) with prosthetic valve; open carotid artery approach	Another alternative access site, less common.	Both
33366	Transcatheter aortic valve implantation (TAVI)/replacement (TAVR) with prosthetic valve; transapical approach	Access through the apex of the heart, requiring a small incision in the chest.	Both
33367	Transcatheter aortic valve implantation (TAVI)/replacement (TAVR) with prosthetic valve; cerebral embolic protection (List separately in addition to code for primary procedure)	Add-on code for embolic protection device. Always billed with a primary TAVR code.	Both
33368	Transcatheter aortic valve implantation (TAVI)/replacement (TAVR) with prosthetic valve; implantation of a valve-in-valve in a previously implanted, non-coronary, prosthetic valve, percutaneous femoral artery approach	Specific for valve-in-valve procedures via percutaneous femoral access.	Both
33369	Transcatheter aortic valve implantation (TAVI)/replacement (TAVR) with prosthetic valve; implantation of a valve-in-valve in a previously implanted, non-coronary, prosthetic valve, open femoral artery approach	Specific for valve-in-valve procedures via open femoral access.	Both
00560	Anesthesia for procedures on the heart, pericardium, and great vessels of chest; without pump oxygenator	Common anesthesia code for TAVR.	Professional
00562	Anesthesia for procedures on the heart, pericardium, and great vessels of chest; with pump oxygenator	Less common for TAVR, but possible in complex cases or conversions.	Professional

Detailed Breakdown

The intricacies of TAVR billing extend far beyond simply selecting the primary procedure code. A thorough understanding of associated services, diagnostic requirements, payer policies, and compliance guidelines is crucial for maximizing reimbursement and minimizing denials.

Core TAVR CPT Codes Explained

The family of TAVR CPT codes (33361-33369) describes the transcatheter replacement of the aortic valve. The specific code chosen depends on the access site utilized for the procedure.

CPT 33361: The Percutaneous Femoral Artery Approach

CPT 33361 is the most frequently reported code for TAVR. It describes the procedure performed via a percutaneous (through the skin) approach through the femoral artery. This minimally invasive technique is preferred due to lower complication rates and faster recovery times compared to open surgery. When billing for CPT code 33361, it’s critical to ensure that the medical record clearly documents the percutaneous femoral access and the medical necessity for the TAVR procedure.

For Medicare beneficiaries, coverage for TAVR, particularly when using CPT code 33361, is governed by National Coverage Determination (NCD) 20.32. This NCD mandates that TAVR procedures must be performed at facilities participating in a national, audited registry. Furthermore, for specific patient populations (e.g., intermediate-risk patients), the NCD historically required participation in a clinical study. Therefore, a crucial question arises: what clinical trial number is needed for CPT code 33361? While the NCD has evolved, the requirement for participation in a CMS-approved registry, such as the STS/ACC TVT Registry, remains. The facility’s participation in this registry, and the submission of patient data to it, is a prerequisite for Medicare reimbursement. While a specific “clinical trial number” isn’t always required on the claim form itself, the facility must attest to meeting the NCD requirements, which includes registry participation and, for certain indications, may still involve clinical trial enrollment. Always verify the latest NCD 20.32 guidelines on the CMS website.

CPT 33363 and Other Access Sites

While CPT code 33361 covers the most common approach, other codes are used for alternative access sites:

• 33362: Open femoral artery approach. Used when percutaneous access to the femoral artery is not feasible, requiring a surgical cut-down to expose the vessel.
• 33363: Open subclavian artery approach. This code is utilized when the subclavian artery is accessed via an open surgical technique, often chosen for patients with severe peripheral vascular disease precluding femoral access.
• 33364: Open direct aortic approach. This involves a small incision in the chest (mini-thoracotomy or sternotomy) to directly access the aorta.
• 33365: Open carotid artery approach. A less common alternative, involving an open surgical approach to the carotid artery.
• 33366: Transapical approach. This involves accessing the heart through a small incision in the chest wall directly into the apex of the left ventricle.

The choice of access site is a critical clinical decision, and accurate documentation is essential to support the chosen CPT code. Each of these codes represents a distinct surgical effort and resource utilization.

TAVR vs. Surgical Aortic Valve Replacement

It’s important to distinguish TAVR codes from traditional surgical aortic valve replacement CPT codes. Open surgical aortic valve replacement (SAVR) typically uses codes like 33405 (Replacement, aortic valve; with cardiopulmonary bypass) or 33406 (Replacement, aortic valve; with coronary artery bypass procedure). These codes reflect a significantly more invasive procedure with different resource intensity and recovery profiles. TAVR codes are specifically for the transcatheter approach, reflecting the distinct methodology.

Pre-Procedure & Post-Procedure Services

TAVR is not a standalone procedure; it’s part of a comprehensive patient care pathway that includes extensive pre-operative evaluation and post-operative management.

Diagnostic Imaging for TAVR

Extensive imaging is crucial for TAVR planning. This includes assessing the aortic valve, aortic annulus, and vascular access routes. Common imaging studies and their associated CPT codes include:

• Computed Tomography Angiography (CTA): TAVR CTA billing CPT codes are vital.
  • 75574: CTA, heart, with contrast material, for evaluation of cardiac structure and morphology (including 3D postprocessing, in conjunction with 75571, 75572, 75573).
  • 75635: Angiography, abdominal aorta and bilateral iliofemoral lower extremity, catheter, by serialography, radiological supervision and interpretation. (Often used for access route planning).
  • 76380: Computed tomography, unenhanced, other than head or spine, followed by contrast material(s) and further sections (often for chest/abdomen/pelvis).
• Echocardiography:
  • 93306: Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete study.
  • 93312: Echocardiography, transesophageal, real-time with image documentation (2D) (TEE). Often performed intraoperatively.
• Cardiac Catheterization:
  • 93458: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, when performed, and all associated radiological supervision and interpretation; with left heart catheterization.
  • 99211-99215 / 99202-99205: Evaluation and Management (E/M) codes for pre-procedural consultations and follow-up visits.

Proper documentation of medical necessity for each imaging study is paramount to avoid denials.

Anesthesia Coding

Anesthesia for TAVR procedures typically involves general anesthesia. The most common CPT codes for anesthesia services are:

• 00560: Anesthesia for procedures on the heart, pericardium, and great vessels of chest; without pump oxygenator. This is the most frequently used code for TAVR.
• 00562: Anesthesia for procedures on the heart, pericardium, and great vessels of chest; with pump oxygenator. This code would be used if cardiopulmonary bypass is required, which is rare for TAVR but could occur in cases of conversion to open surgery.
• 00563: Anesthesia for procedures on the heart, pericardium, and great vessels of chest; with pump oxygenator with hypothermic circulatory arrest. Even rarer for TAVR.

Anesthesia providers should also append appropriate modifiers (e.g., AA for personally performed, QK for medical direction) and document total time units.

ICD-10 Codes for TAVR

Accurate diagnosis coding is as critical as CPT coding. The primary diagnosis for TAVR is severe aortic stenosis. However, a comprehensive set of ICD-10 codes is often required to fully describe the patient’s condition, comorbidities, and any complications.

• Primary Diagnosis:
  • I35.0: Nonrheumatic aortic valve stenosis (most common).
  • I06.0: Rheumatic aortic stenosis (if rheumatic origin).
  • I35.2: Nonrheumatic aortic valve insufficiency with stenosis.
  • I06.2: Rheumatic aortic insufficiency with stenosis.
• Associated Conditions/Comorbidities:
  • I50.x: Heart failure (e.g., I50.20 for unspecified systolic heart failure, I50.30 for unspecified diastolic heart failure).
  • I10: Essential (primary) hypertension.
  • I25.10: Atherosclerotic heart disease of native coronary artery without angina pectoris.
  • I70.2xx: Atherosclerosis of arteries of extremities (relevant for access site issues).
  • E11.xx: Type 2 diabetes mellitus.
  • N18.x: Chronic kidney disease.
  • J44.9: Chronic obstructive pulmonary disease, unspecified.
• Complications (Post-Procedure):
  • T82.898A: Other specified complication of cardiac and vascular prosthetic devices, implants and grafts, initial encounter (for complications related to the TAVR valve itself).
  • I97.1xx: Postprocedural cardiac functional disturbances.
  • I97.6xx: Postprocedural hemorrhage and hematoma of a circulatory system organ or structure following a cardiac procedure.
  • I97.8xx: Other postprocedural complications and disorders of the circulatory system.
  • R07.x: Chest pain (if new or persistent post-op).
  • J96.x: Respiratory failure (if post-op complication).
• Status Codes/Encounters:
  • Z95.2: Presence of prosthetic heart valve (for follow-up visits after TAVR).
  • Z01.810: Encounter for preprocedural cardiovascular examination.
  • Z01.818: Encounter for other preprocedural examination.
  • Z98.89: Other specified postprocedural states (e.g., for routine post-op checks).

Always code to the highest level of specificity and ensure that all diagnoses are supported by clinical documentation. For more detailed guidance on cardiovascular ICD-10 codes, refer to our comprehensive guide on cardiovascular diagnosis coding.

Reimbursement & Coverage Policies (2025 & 2026)

Reimbursement for TAVR is complex, influenced by Medicare, Medicaid, and commercial payer policies, which can vary significantly.

Medicare Fee Schedule (2025 & 2026)

The Medicare Fee Schedule (MFS) dictates reimbursement for professional services, while facility reimbursement for TAVR falls under the Inpatient Prospective Payment System (IPPS) for hospitals, typically assigned to a specific Diagnosis-Related Group (DRG). For 2025, we anticipate continued adjustments to Relative Value Units (RVUs) and the conversion factor. While specific 2026 CPT rates and reimbursement details from the Medicare Fee Schedule are not yet finalized, historical trends suggest incremental changes. Providers should expect annual updates to RVUs and the conversion factor, which directly impact professional fee reimbursement. Hospital DRG payments are also subject to annual recalibration. It is crucial to monitor the CMS Physician Fee Schedule and IPPS final rules as they are released in late fall each year for the upcoming calendar year. For example, a TAVR procedure (e.g., 33361 CPT code) performed in a hospital setting will have a facility payment (DRG) and a separate professional payment (MFS) for the physician(s) involved. The 2025 rates will be published in late 2024, and 2026 rates in late 2025. Providers should budget for potential slight decreases or minimal increases in reimbursement, given ongoing efforts to control healthcare costs.

Payer-Specific Requirements

Beyond Medicare, commercial payers have their own specific requirements for TAVR coverage. These often include:

• Prior Authorization: Almost universally required. This process can be extensive, demanding detailed clinical documentation, imaging reports, and multidisciplinary heart team meeting notes.
• Medical Necessity Criteria: Payers like Aetna, Blue Cross Blue Shield (BCBS), and UnitedHealthcare publish detailed medical policies for TAVR. These policies often align with professional society guidelines (e.g., ACC/AHA) but may have unique stipulations regarding patient risk stratification (e.g., intermediate, high, or prohibitive surgical risk), specific anatomical criteria, and contraindications.
• Clinical Trial Participation: While less stringent than Medicare’s historical requirements for all TAVR patients, some commercial payers may still require or prefer enrollment in clinical trials for specific indications or newer devices. Always check the payer’s most current medical policy.
• Documentation of Heart Team Discussion: Many payers require documentation of a multidisciplinary heart team evaluation and consensus decision for TAVR, similar to Medicare’s NCD.

It is imperative to consult each payer’s specific medical policy prior to performing the procedure. Failure to meet these requirements is a leading cause of denials.

Clinical Trial Participation for CPT Code 33361

As mentioned, for Medicare, the NCD 20.32 has evolved. While the strict “clinical trial” requirement for all TAVR patients has been relaxed, the requirement for facilities to participate in a national, audited registry (like the STS/ACC TVT Registry) remains. This registry collects data on all TAVR procedures to monitor outcomes and ensure quality. When billing for CPT code 33361, the facility must attest to meeting these NCD requirements. For specific investigational devices or indications not yet fully covered, actual clinical trial enrollment with a specific trial number might still be necessary. Always confirm the latest NCD and any specific payer requirements regarding clinical trial or registry participation.

NCCI Edits and Bundling

The National Correct Coding Initiative (NCCI) edits are crucial for preventing improper payments due to incorrect coding. NCCI edits identify code pairs that should not be billed together (PTP edits) or services that are integral to a

FAQ: Common Questions Answered

What are the primary CPT codes for TAVR procedures in 2026?

For 2026, the core CPT codes for Transcatheter Aortic Valve Replacement (TAVR) procedures remain centered around the approach used. The most frequently utilized code is 33361, which covers TAVR performed via a percutaneous femoral artery approach. This is often the preferred, less invasive method. When a percutaneous approach isn’t feasible, and an open surgical cut-down to the femoral artery is required, code 33362 is used. For cases where access is gained through an open subclavian artery approach, 33363 is the appropriate code. It’s crucial to remember that while these codes define the procedural access, successful billing also hinges on meticulous documentation of medical necessity, patient selection criteria, and adherence to payer-specific guidelines, especially concerning clinical trial participation for Medicare beneficiaries.

How do Medicare reimbursement rates for TAVR CPT codes compare in 2026?

While specific dollar amounts for 2026 are subject to annual updates by CMS, the comparative reimbursement for TAVR CPT codes under Medicare generally reflects the complexity and resource intensity of the procedure. TAVR procedures are typically reimbursed under the Inpatient Prospective Payment System (IPPS) for hospital services, assigned to specific Diagnosis-Related Groups (DRGs) that account for the procedure, comorbidities, and complications. Physician services are reimbursed via the Medicare Physician Fee Schedule (MPFS). Factors influencing comparative rates include the facility setting (inpatient vs. potentially outpatient for select low-risk cases), geographic wage indices, and the specific DRG assignment. Crucially, Medicare’s National Coverage Determination (NCD) for TAVR often ties coverage and thus reimbursement to specific criteria, including participation in a clinical study or registry for certain patient populations, which can impact the administrative burden and, indirectly, the effective reimbursement process. Providers must stay abreast of the annual final rules to understand the precise rate adjustments and policy changes.

What are common challenges and denial codes for TAVR billing and how can they be appealed?

TAVR billing presents several nuanced challenges. A primary hurdle is demonstrating strict medical necessity, as payers, particularly Medicare, have stringent coverage criteria often linked to patient risk profiles and shared decision-making. Lack of proper documentation supporting these criteria is a frequent cause for denial. Other challenges include incorrect CPT code selection for the access method, missing or inappropriate modifiers, failure to obtain prior authorization, and issues related to clinical trial participation documentation. Common denial reasons, though not always specific “codes,” often relate to “services not medically necessary,” “lack of documentation,” or “pre-authorization not obtained.” To appeal a denial, a robust strategy is essential. This typically involves a thorough review of the denial reason, gathering comprehensive clinical documentation (e.g., heart team meeting notes, imaging reports, physician orders, operative reports), and crafting a detailed appeal letter that directly addresses the payer’s concerns with supporting evidence. Peer-to-peer reviews with the payer’s medical director can also be highly effective, allowing a clinician to explain the medical rationale directly. Understanding the payer’s specific appeal process and timelines is paramount for success.

Why is comprehensive documentation critical for successful TAVR billing and avoiding denials?

Comprehensive documentation is not merely a best practice; it is the bedrock of successful TAVR billing and the most potent defense against denials. Given the high cost and complexity of TAVR, payers scrutinize claims meticulously. Detailed documentation provides the irrefutable evidence that the procedure was medically necessary, met all payer-specific coverage criteria (including patient selection, risk assessment, and shared decision-making by a multidisciplinary heart team), and was performed according to established protocols. This includes, but is not limited to, pre-procedure evaluations, imaging results, heart team meeting minutes, operative reports detailing the access method and device used, and post-procedure care. Without this granular detail, even a perfectly executed procedure can lead to a denial, as the claim lacks the clinical narrative required to justify reimbursement. Robust documentation ensures compliance, facilitates accurate coding, and provides the necessary ammunition for a successful appeal should a denial occur, ultimately safeguarding revenue integrity for the healthcare provider.

External Resources & Authority Links

• For more detailed insights, refer to the official CMS Medicare guidelines.
• For more detailed insights, refer to the CMS guidelines.